157 related articles for article (PubMed ID: 20698392)
1. Multi-modality therapy for metastatic colorectal cancer-ready for prime time?
Chua TC; Marshall JL; Marshall MB; Esquivel J
Am Surg; 2010 Jul; 76(7):777-8. PubMed ID: 20698392
[No Abstract] [Full Text] [Related]
2. An increasingly common challenge: management of the complete responder with multi-focal metastatic colorectal cancer.
Schrag D; Weiser M; Schattner M; Shia J; Akhurst T
J Clin Oncol; 2005 Mar; 23(9):1799-802. PubMed ID: 15774773
[No Abstract] [Full Text] [Related]
3. [Four cases of locally advanced colorectal cancer resected successfully after preoperative chemotherapy].
Yoneda A; Okada K; Matsuo M; Kajiyama M; Kishikawa H
Gan To Kagaku Ryoho; 2011 Oct; 38(10):1699-703. PubMed ID: 21996971
[TBL] [Abstract][Full Text] [Related]
4. Metastatic colorectal cancer: is surgery necessary?
Schmidt C
J Natl Cancer Inst; 2009 Aug; 101(16):1113-5. PubMed ID: 19671774
[No Abstract] [Full Text] [Related]
5. [Systemic chemotherapy in metastatic colorectal adenocarcinomas].
Bécouarn Y; Brunet R; Ravaud A; Bussières E; Lagarde P
Gastroenterol Clin Biol; 1992; 16(2):166-76. PubMed ID: 1568545
[No Abstract] [Full Text] [Related]
6. Undiagnosed Case of Signet Ring Cell Colorectal Carcinoma: A Case Report and Review of the Literature.
Henry M; Delavari N; Webber J
Clin Colorectal Cancer; 2020 Sep; 19(3):e83-e86. PubMed ID: 32586730
[No Abstract] [Full Text] [Related]
7. Incomplete operative removal of colorectal liver metastases followed by chemotherapy decreases survival in comparison to chemotherapy alone.
Popov IP; Milicevic M; Kecmanovic D; Tomasevic Z; Radosevic-Jelic Lj; Borojevic N; Micev MT; Kezic I
J Exp Clin Cancer Res; 2006 Sep; 25(3):313-9. PubMed ID: 17167970
[TBL] [Abstract][Full Text] [Related]
8. [Cytoreductive surgery as an alternative to palliative operations in oncology (the model of treatment of stage IV colorectal cancer)].
Grinev MV
Vestn Khir Im I I Grek; 2002; 161(6):100-3. PubMed ID: 12638509
[TBL] [Abstract][Full Text] [Related]
9. OPTIMOX1 in advanced colorectal cancer: lack of evidence for a stop-and-go strategy.
Rosa DD; Ismael GF; de Azambuja E; Braga S; Cardoso F; Bleiberg H
J Clin Oncol; 2006 Nov; 24(32):5176-7; author reply 5177. PubMed ID: 17093286
[No Abstract] [Full Text] [Related]
10. [Colorectal carcinoma--approval of eloxatine in adjuvant therapy--better chances for recovery].
Krankenpfl J; 2004; 42(7-10):234. PubMed ID: 15675396
[No Abstract] [Full Text] [Related]
11. [First-line metastatic cancer of the colon].
Raoul JL
Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B150-3. PubMed ID: 12843951
[No Abstract] [Full Text] [Related]
12. [A CR case of colorectal cancer given 39 courses of FOLFOX].
Kobayashi K; Kaneko M; Fujiwara M; Otsubo M; Ogura S; Isaka T; Imai N; Naota H; Taniguchi K
Gan To Kagaku Ryoho; 2009 Jan; 36(1):135-8. PubMed ID: 19151580
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
[TBL] [Abstract][Full Text] [Related]
14. [Colorectal carcinoma: what's new?].
Pox C; Schmiegel W; Reinacher-Schick A
Dtsch Med Wochenschr; 2012 Dec; 137(49):2577-80. PubMed ID: 23188639
[No Abstract] [Full Text] [Related]
15. [A successfully resected case of colorectal cancer with multiple liver metastases treated with FOLFIRI after failure of mFOLFOX6].
Fukuda H; Tazawa K; Sawada S; Nagata T; Uotani H; Hirokawa S; Yamagishi F; Tsukada K
Gan To Kagaku Ryoho; 2008 Mar; 35(3):507-9. PubMed ID: 18347406
[TBL] [Abstract][Full Text] [Related]
16. [State of art of the radiofrequency ablation of colorectal liver metastases].
Zhao M; Wang JP; Wu PH
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):401-4. PubMed ID: 21875477
[No Abstract] [Full Text] [Related]
17. Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer.
Hochster H; Chachoua A; Speyer J; Escalon J; Zeleniuch-Jacquotte A; Muggia F
J Clin Oncol; 2003 Jul; 21(14):2703-7. PubMed ID: 12860947
[TBL] [Abstract][Full Text] [Related]
18. A phase II trial of modified FOLFOX as first-line chemotherapy in advanced colorectal cancer.
Xiong JP; Zhang L; Zhong LX; Qiu F; Xu J; Tao QS; Xiang XJ; Yu F; Tang XM
Anticancer Drugs; 2007 Oct; 18(9):1103-7. PubMed ID: 17704661
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of modified FOLFOX6 for treatment of metastatic or locally advanced colorectal cancer. A single-institution outcome study.
Matsumoto S; Nishimura T; Kanai M; Mori Y; Nagayama S; Kawamura J; Nomura A; Miyamoto S; Kitano T; Ishiguro H; Yanagihara K; Teramukai S; Sakai Y; Chiba T; Fukushima M
Chemotherapy; 2008; 54(5):395-403. PubMed ID: 18781065
[TBL] [Abstract][Full Text] [Related]
20. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study.
Taïeb J; Artru P; Paye F; Louvet C; Perez N; André T; Gayet B; Hebbar M; Goebel FM; Tournigand C; Parc R; de Gramont A
J Clin Oncol; 2005 Jan; 23(3):502-9. PubMed ID: 15659495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]